Long-acting oral and parenteral dosing of MK-8591 for HIV treatment or prophylaxis. In Special Issue: Abstracts from the 2016 Conference on Retroviruses and Opportunistic Infections
-
- Grobler J
- 作成者
収録刊行物
-
- Top Antivir Med
-
Top Antivir Med 24 391-, 2016